Biggest challenge for CVS last year was its Aetna managed care business, says Jim CramerApril 15, 2025
Portfolio positioning amid tariff uncertainty, Johnson & Johnson’s Q1 earnings beat, HPE stock jumpsApril 15, 2025
I thought banks would benefit from deregulation under Trump, but we haven’t seen it, says Jim CramerApril 15, 2025
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s Jim Cramer breaks down why he’s keeping an eye on shares of Johnson & Johnson.
